Martha Elena Benavides, FNP

Martha Benavides practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Martha Benavides' NPI, 1215105580, was assigned on February 20, 2008. Martha Benavides holds California license 17263.

Martha Benavides' primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Martha Benavides' primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Martha Benavides practices. Vendor and product names are available with a free account.

Family is Martha Benavides' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Martha Benavides is licensed in California.

CMS data shows 271 Medicare services from Martha Benavides across 3 procedure codes in 2024, for 121 Medicare patients. Medicare paid $17,001 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Martha Benavides in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have diabetes, and 75% have high blood pressure. 60% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Martha Benavides' median patient age at 58, with 46% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Martha Benavides for performance year 2024, reported as part of a group. Martha Benavides accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Martha Benavides from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $780.